Feature

Oncology Protocol Challenge

Are you working on an Early Phase Oncology protocol or study concept? Participate in the Accelovance Oncology Protocol Challenge!

What is the Accelovance Protocol Challenge?

Accelovance's Protocol Challenge is an opportunity for a confidential review and discussion of your protocol or concept document. Our experts will review your information and provide a summary of operational, therapeutic, and strategic considerations tailored to your protocol/study concept. This assessment is free of charge, with no obligation of future work. To learn more, click on the link to download an overview of Accelovance's Protocol Challenge as well as information on how to participate.

News

September 30, 2014
Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

June 6, 2014
Stephen Trevisan interview with CEO of PharmaVentures

04/30/2014
Pivotal H7N9 Research Conducted with Accelovance Highlighted in Science Translational Medicine Manuscript

4/23/2014
Stephen Trevisan interview on Executive Leaders Radio

03/06/2014
Accelovance Nominated for TWO 2014 Vaccine Industry Excellence (ViE) Awards - "Best Contract Research Organization" & "Best Clinical Trial Network and Site"

Events

Outsourcing in Clinical Trials – New England
October 7-8, 2014 – Boston, MA–Visit us at Booth #41

Site Solutions Summit
October 10-12, 2014 – Amelia Island, FL

eXL Pharma'sClinical Trials Phase I & Phase IIa
October 15–16, 2014 – Philadelphia, PA

International Partnering Conference BioEurope
November 3-5, 2014Frankfurt, Germany

American Society of Hematology
December 6-9, 2014 – San Francisco, CA